Literature DB >> 11179457

Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor.

S Ahmadi1, C Kotalla, H Gühring, H Takeshima, A Pahl, H U Zeilhofer.   

Abstract

Nociceptin/orphanin FQ (N/OFQ) and nocistatin (NST) are two neuropeptides derived from the same precursor protein that exhibit opposing effects on spinal neurotransmission and nociception. Here, we have used whole-cell, patch-clamp recordings from visually identified neurons in spinal cord dorsal horn slices of genetically modified mice to investigate the role of the N/OFQ receptor (N/OFQ-R) in the modulatory action of both peptides on excitatory glutamatergic and inhibitory glycinergic and gamma-aminobutyric acid (GABA)-ergic synaptic transmission. In wild-type mice, N/OFQ selectively suppressed excitatory transmission in a concentration-dependent manner but left inhibitory synaptic transmission unaffected. In contrast, NST reduced only inhibitory but not alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated excitatory synaptic transmission. N/OFQ-mediated inhibition of excitatory transmission was completely absent in N/OFQ-R receptor-deficient (N/OFQ-R(-/-)) mice and significantly reduced in heterozygous (N/OFQ-R(+/-)) mice, whereas the action of NST on inhibitory neurotransmission was completely retained. To test for the relevance of these results for spinal nociception, we investigated the effects of intrathecally injected N/OFQ in the mouse formalin test, an animal model of tonic pain. N/OFQ (3 nmol/mouse) induced significant antinociception in wild-type mice, but had no antinociceptive effects in N/OFQ-R(-/-) mice. These results indicate that the inhibitory action of N/OFQ on excitatory glutamatergic synaptic transmission and its spinal antinociceptive action are mediated via the N/OFQ receptor, whereas the action of NST is independent of this receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179457     DOI: 10.1124/mol.59.3.612

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype.

Authors:  Heiko Reinold; Seifollah Ahmadi; Ulrike B Depner; Beate Layh; Cornelia Heindl; May Hamza; Andreas Pahl; Kay Brune; Shuh Narumiya; Ulrike Müller; Hanns Ulrich Zeilhofer
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Authors:  Jamil Ahsan Kazi
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

Review 3.  Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics.

Authors:  Norikazu Kiguchi; Huiping Ding; Shiroh Kishioka; Mei-Chuan Ko
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

Review 4.  [Physiology of pain].

Authors:  K Messlinger; H O Handwerker
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

5.  Roles of K+ and cation channels in ORL-1 receptor-mediated depression of neuronal excitability and epileptic activities in the medial entorhinal cortex.

Authors:  Huiming Li; Binqi Hu; Hao-Peng Zhang; Cody A Boyle; Saobo Lei
Journal:  Neuropharmacology       Date:  2019-04-15       Impact factor: 5.250

6.  Nocistatin sensitizes TRPA1 channels in peripheral sensory neurons.

Authors:  Luca Avenali; Oli Abate Fulas; Julia Sondermann; Pratibha Narayanan; David Gomez-Varela; Manuela Schmidt
Journal:  Channels (Austin)       Date:  2016-06-30       Impact factor: 2.581

7.  Towards a receptor for nocistatin?

Authors:  E E Johnson; M Connor
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

8.  Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.

Authors:  M Fantin; C Fischetti; C Trapella; M Morari
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

Review 9.  Fast synaptic inhibition in spinal sensory processing and pain control.

Authors:  Hanns Ulrich Zeilhofer; Hendrik Wildner; Gonzalo E Yévenes
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

10.  Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.

Authors:  Heeseung Lee
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.